ZAMBON, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.046
AS - Asia 2.668
EU - Europa 2.270
SA - Sud America 642
AF - Africa 571
OC - Oceania 387
Continente sconosciuto - Info sul continente non disponibili 30
Totale 14.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.735
SG - Singapore 931
IT - Italia 571
HK - Hong Kong 556
CN - Cina 490
BR - Brasile 435
AU - Australia 338
DE - Germania 272
FI - Finlandia 202
UA - Ucraina 159
PL - Polonia 115
FR - Francia 110
GB - Regno Unito 102
SE - Svezia 102
VN - Vietnam 95
RU - Federazione Russa 85
NL - Olanda 74
TR - Turchia 48
IN - India 47
AT - Austria 41
MX - Messico 37
CI - Costa d'Avorio 34
IQ - Iraq 34
CA - Canada 33
IE - Irlanda 32
EC - Ecuador 29
AR - Argentina 28
KR - Corea 28
VE - Venezuela 25
CO - Colombia 24
IS - Islanda 24
TN - Tunisia 24
ZA - Sudafrica 23
AL - Albania 22
AE - Emirati Arabi Uniti 21
ES - Italia 21
JO - Giordania 21
UY - Uruguay 21
DK - Danimarca 20
GR - Grecia 20
ID - Indonesia 20
JP - Giappone 20
AO - Angola 19
BG - Bulgaria 19
GF - Guiana Francese 19
HN - Honduras 19
HU - Ungheria 19
IR - Iran 19
PY - Paraguay 19
UZ - Uzbekistan 19
AD - Andorra 18
BJ - Benin 18
PH - Filippine 18
RO - Romania 18
SA - Arabia Saudita 18
SN - Senegal 18
TJ - Tagikistan 18
CY - Cipro 17
GT - Guatemala 17
JM - Giamaica 17
MA - Marocco 17
MY - Malesia 17
MZ - Mozambico 17
AZ - Azerbaigian 16
CH - Svizzera 16
CV - Capo Verde 16
EG - Egitto 16
KG - Kirghizistan 16
LC - Santa Lucia 16
LV - Lettonia 16
PE - Perù 16
SD - Sudan 16
SO - Somalia 16
BD - Bangladesh 15
BE - Belgio 15
BO - Bolivia 15
CW - ???statistics.table.value.countryCode.CW??? 15
DZ - Algeria 15
GA - Gabon 15
GH - Ghana 15
MG - Madagascar 15
PS - Palestinian Territory 15
SK - Slovacchia (Repubblica Slovacca) 15
TT - Trinidad e Tobago 15
ZW - Zimbabwe 15
KH - Cambogia 14
MD - Moldavia 14
MN - Mongolia 14
NI - Nicaragua 14
PA - Panama 14
UG - Uganda 14
AM - Armenia 13
BA - Bosnia-Erzegovina 13
BF - Burkina Faso 13
BS - Bahamas 13
BW - Botswana 13
DO - Repubblica Dominicana 13
EE - Estonia 13
GN - Guinea 13
HR - Croazia 13
Totale 13.990
Salva come PNG Salva come JPEG
Città #
Fairfield 1.071
Woodbridge 780
Ashburn 642
Singapore 589
Houston 573
Jacksonville 543
Hong Kong 542
Ann Arbor 496
Seattle 429
Cambridge 428
Chandler 391
Wilmington 390
Sydney 320
Princeton 216
Beijing 194
Boardman 186
San Diego 150
Santa Clara 115
Bytom 97
Des Moines 81
Medford 81
Padova 79
Helsinki 75
Roxbury 74
Munich 48
Milan 43
Nanjing 43
Rome 42
Los Angeles 36
São Paulo 36
Abidjan 34
Dong Ket 34
Guangzhou 33
Ho Chi Minh City 26
Vienna 25
Shenyang 24
Dublin 23
London 23
Chicago 22
Hebei 22
Nuremberg 22
Amman 21
Hefei 21
Rio de Janeiro 21
New York 20
Nanchang 19
Buffalo 18
Dushanbe 18
Reykjavik 18
Tashkent 18
Andorra la Vella 17
Dakar 17
Jiaxing 17
Luanda 17
Norwalk 17
Stockholm 17
Bishkek 16
Turku 16
Castries 15
Cotonou 15
Harare 15
Libreville 15
Antananarivo 14
Baku 14
Cayenne 14
Kampala 14
Lima 14
Montevideo 14
Praia 14
Accra 13
Conakry 13
Hanoi 13
Kigali 13
Managua 13
Maputo 13
Nassau 13
Redondo Beach 13
Ulan Bator 13
Yerevan 13
Cairo 12
Catania 12
Dili 12
Istanbul 12
Kingstown 12
Nouakchott 12
Panama City 12
Phnom Penh 12
Vientiane 12
Willemstad 12
Antakya 11
Changsha 11
Guatemala City 11
Jeddah 11
Noumea 11
Quito 11
Riga 11
Tirana 11
Addis Ababa 10
Athens 10
Baghdad 10
Totale 9.912
Salva come PNG Salva come JPEG
Nome #
Mappatura Genetica dell' Ipercolesterolemia Familiare: dati preliminari dell'esperienza padovana 385
Lipid-lowering in diabetes: An update 359
Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques. A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy. 183
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity 178
Dyslipidemia of the Plurimetabolic Syndrome and risk of cerebrovascular events 176
Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells 176
Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype. 176
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy 169
SGLT2 Inhibitors and the Diabetic Kidney 166
Review article: the metabolic syndrome--a chronic cardiovascular inflammatory condition. 165
Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia 161
Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: A flag for non-HDL-C 160
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement 156
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia 155
Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R3i) 152
Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins 144
A common hepatic lipase gene promoter variant determines clinical response to intensive lipid lowering treatment 141
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential 141
Genetic Diagnosis of Familial Hypercholesterolaemia: preliminary data from the University of Padua outpatient lipid clinic. 139
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? 139
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase mediated changes in LDL density 138
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity 134
Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease 133
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 133
γ-Hydroxybutyric acid-induced psychosis and seizures. 131
A common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment 130
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 130
PLASMA TRIGLYCERIDE AND LDL HETEROGENEITY IN FAMILIAL COMBINED HYPERLIPIDEMIA 127
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol 127
Pro-atherogenic postprandial profile: Meal induced changes of lipoprotein sub-fractions and inflammation markers in obese boys 126
LIPOPROTEIN COMPOSITIONAL ABNORMALITIES IN TYPE 1 (INSULIN-DEPENDENT) DIABETIC PATIENTS 124
Association between the -514 C to T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis 124
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile 121
Lipoprotein abnormalities in well-treated type II diabetic patients. 117
Reducing vascular risk in the diabetic patient: implications from the FIELD study 115
Premature coronary artery disease and apolipoprotein B and apolipoprotein A-I 114
The Plurimetabolic Syndrome: qualitative lipoprotein abnormalities and atherosclerosis 113
Residual cardiovascular risk in secondary prevention. 112
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 112
Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease. 112
Plasma phospholipid fatty acid composition, lipid oxidation and inflammatory parameters in a population of fishermen 108
Type 2 diabetes patients: profiles, treatment and daily practice 107
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy 106
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy 106
Non-pharmacological control of plasma cholesterol levels. 106
FAMILIAL COMBINED HYPERLIPIDEMIA AND GENETIC RISK FOR ATHEROSCLEROSIS 106
The Multicentre Atorvastatin Plaque Stabilisation (MAPS) Study 105
DRUG TREATMENT OF HYPERLIPIDEMIA IN THE ELDERLY: A MULTICENTER DOUBLE BLIND TRIAL WITH PRAVASTATIN AND BEZAFIBRATE 104
The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. 104
DIMERIC LIPOPROTEIN LIPASE ACTIVITY IS BOUND TO TRIGLYCERIDE-RICH LIPOPROTEINS IN POSTHEPARIN PLASMA 102
Effect of Ritonavir on lipids and post-heparin lipase activities in normal subjects 102
Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia 102
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 102
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice 100
Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease. 98
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes 97
COMPOSITIONAL DIFFERENCES OF LOW DENSITY LIPOPROTEIN (LDL) PARTICLES IN NORMAL SUBJECTS WITH LDL PHENOTYPE A AND LDL PHENOTYPE B 96
Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population the Italian longitudinal study on aging 95
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. 95
The role of fenofibrate in clinical practice. 95
Residual macrovascular risk in 2013: what have we learned? 95
Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. 95
Changes in LDL density across the menopausal transition 94
Statin treatment and carotid plaque composition: A review of clinical studies 94
Liporpotein distribution and composition during simvastatin treatment in heterozygous FH patients 93
A common polymorphism of the hepatic lipase gene as a determinant of LDL particle density and prevalence of macrophages in carotid plaque of patients with cerebrovascular disease 93
Le linee guida nella prevenzione della cardiopatia ischemica 93
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 92
The new ACC/AHA guidelines on the treatment of dyslipidemia: cons. 92
C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? 91
Le basi razionali della terapia delle ipercolesterolemie 91
Consenso sobre tratamiento farmacológico de la dislipidemia aterogénica con terapia combinada estatina-fenofibrato 90
Reported muscle symptoms during statin treatment among Italian dyslipidemic patients in the real-life setting: The Prosisa Study 90
La lipasi epatica influenza il metabolismo lipoproteico nell'uomo con meccanismo indipendente dalla sua attività enzimatica 89
THE LIPOPROTEIN METABOLISM IN THE PLURIMETABOLIC SYNDROME 88
A common polymorphism in the promoter of the hepatic lipase gene significanlty affect hepatic lipase activity, LDL density and HDL2 cholesterol 87
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. 87
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 87
Progress and prospects of biological approaches targeting PCSK9 for cholesterol-lowering, from molecular mechanism to clinical efficacy 86
PARAOXONASE GENOTYPES, LIPOPROTEIN LIPASE ACTIVITY AND HIGH DENSITY LIPOPROTEINS 85
Lessons from PROMINENT and prospects for pemafibrate 84
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma 84
Serum lipoprotein profile and APOE genotype in Alzheimer's disease 84
EFFECT OF HEPATIC LIPASE ON LDL IN NORMAL MALES AND THOSE WITH CORONARY ARTERY DISEASE 83
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR-{alpha} Activators. Clinical and Experimental Evidence. 83
I farmaci che riducono la mortalità: gli ipolipemizzanti 83
Leptin is associated with the size of the apolipoprotein(a) particle in African tribal populations living on fish or vegetarian diet 82
LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease 82
Dietary and drug treatment of dyslipidemias 80
Relevance of the -514 C to T hepatic lipase gene promoter variant in predicting individual CAD response to intensive lipid-lowering therapy 79
FAMILIAL COMBINED HYPERLIPIDEMIA AND FAMILIAL HYPERTRIGLYCERIDEMIA 79
LIPOPROTEIN SUB-FRACTION LEVELS AND COMPOSITION IN OBESE SUBJECTS BEFORE AND AFTER GASTROPLASTY 79
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. 79
Hepatic lipase as a focal point for coronary artery disease regression with lipid lowering therapy 78
PREVENTION OF RAISED LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN A PATIENT WITH HYPERCHOLESTEROLEMIA AND LIPOPROTEIN LIPASE DEFICIENCY 78
LDL piccole e dense, placca carotidea instabile ed eventi cerebrovascolari in pazienti sottoposti ad intervento di endarteriectomia carotidea 78
Atorvastatin Reduces Macrophage Accumulation in the Atherosclerotic Plaque: A Comparison versus Non-statin Based Regimen in Patients Undergoing Carotid Endarterectomy 77
TRATTAMENTO DELL'OBESITA' 75
In vivo evidence for a role hepatic lipase in human apo B containing lipoprotein metabolism, independent of its lipolytic activity 75
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction 75
Totale 11.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.759
article - articoli 43.626
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.927
Totale 96.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.220 0 0 80 122 36 98 44 156 211 199 187 87
2021/20221.664 49 229 208 129 54 96 76 169 43 56 175 380
2022/20231.055 272 72 7 97 155 141 6 81 118 13 68 25
2023/2024623 26 68 62 66 37 40 49 24 38 20 96 97
2024/20253.160 14 205 156 123 366 77 156 276 298 148 604 737
2025/20263.153 455 1.032 1.666 0 0 0 0 0 0 0 0 0
Totale 14.786